Clinical implications of adiponectin and inflammatory biomarkers in type 2 diabetes mellitus

Disease Markers

Volumn 27, Issue 6, 2009, Pages 269-278

  Swellam, Menha ^a   Mahmoud, Magda Sayed ^a   Ali, Adel Abdel Fatah ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

Author keywords

Adiponectin; C reactive protein; Fibrinogen; Type 2 diabetes mellitus

Indexed keywords

ADIPONECTIN; BIOCHEMICAL MARKER; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; FIBRINOGEN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UREA;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL;

EID: 77249179169     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/703927     Document Type: Article

References (29)

1. R. Sicree, J. Shaw, P. Zimmet and R. Tapp, The global burden of diabetes, in: Diabetes atlas 2003 (2nd edR), D. Gan Ed., Brussels, Belgium' International Diabetes Federation, 2003.
2. J. Calles-Escandon and M. Cipolla, Diabetes and endothelial dysfunction: A clinical perspective, Endocrine Reviews 22 (2001), 36-52.
3. D. Streja, P. Cressey and S.W. Rabkin, Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus, J Diabetes Complications 17 (2003), 120-127.
4. L. Qi, J.B. Meigs, S. Liu, J.E. Manson, C. Mantzoros and F.B. Hu, Dietary fibers and glycemic load, obesity, and plasma adiponectin levels in women with type 2 diabetes, Diabetes Care 29 (2006), 1501-1505.
5. S.D. Poppitt, G.F. Keogh, F.E. Lithander, Y. Wang, T.B. Mulvey, Y.-K. Chan, B.H. McArdle and G.J.S. Cooper, Postprandial response of adiponectin, interleukin-6, tumor necrosis Factor- and C-reactive protein to a high-fat dietary load, Nutrition 24 (2008), 322-329.
6. A.D. Pradhan, J.E. Manson, N. Rifai, J.E. Buring and P.M. Ridker, C-reactive protein, Interleukin 6, and risk of developing type 2 diabetes mellitus, JAMA 286 (2001), 327-334.
7. E. Corrado, M. Rizzo, I. Muratori, G. Coppola and S. Novo, Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes, Archives of Medical Res 37 (2006), 1004-1009.
8. K. Takebayashi, M. Suetsugu, R. Matsutomo, S.Wakabayashi, Y. Aso and T. Inukai, Correlation of high-sensitivity C-reactive protein and plasma fibrinogen with individual complications in patients with type 2 diabetes, South Med J 99 (2006), 23-27.
9. M. Javorsky, M. Kozarova, J. Salagovic and T. Kac, Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients, Physiol Res 55 (2006), 55-62
10. M.D. Vestra, M. Mussap, P. Gallina, M. Bruseghin, A.M. Cernigoi, A. Saller, M. Plebani and P. Fioretto, Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes, J Am Soc Nephrol 16 (2005), S78-2.
11. Z. Bloomgarden, European Association for the Study of Diabetes (EASD). Meeting, Diabetic Care 25 (2002), 1229-1236
12. M.R. Hayden, J.R. Sowers and S.C. Tyagi, The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded, Cardiovascular Diabetology 4 (2005), 1-20.
13. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 20 (1997), 1183-1197.
14. E. Lopez-Garcia, M.B. Schulze, T.T. Fung, J.B. Meigs, N. Rifai, J.E. Manson and F.B. Hu, Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction, Am J Clin Nutr 80 (2004), 1029-1035.
15. A.H. Berg, T.P. Combs and P.E. Schever, ACRP30/ Adiponectin: An adiponectin regulating glucose and lipid metabolism trends. Endocrinol, Meta 13 (2002), 84-85.
16. N.S. Cooks and D. Ubben, Fibrinogen as a major risk factor in cardiovascular disease, T PS 11 (1990), 444-451.
17. C.E. Metz, Basic principles of ROC analysis, Semin Nucl Med 8 (1978), 283.
18. C.S. Mantzoros, T. Li, J.E. Manson, J.B. Meigs and F.B. Hu, Circulating adiponectin levels are Associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes, J Clin Endocrin & Metab 90 (2005), 4542-4548.
19. I. Gornik, O. Gornik and V. Gasparovic, HbA1c is outcome predictor in diabetic patients with sepsis, Diabetes Res and Clin Practice 77 (2007), 120-125.
20. R. Barazzoni, M. Zanetti, G. Davanzo, E. Kiwanuka and P. Carraro, Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: Correlation with plasma glucagon concentrations.
21. U.J. Tietge, C. Maugeais and S. Land-Katz, Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and Apo A-I in response to inflammation in human apo A-I transgenic mice, Arterioscler Thromb Vasc Biol 22 (2002), 1213-1218.
22. T. Kazumi, A. Kawaguchi, T. Hirano and G. Yoshino, Creactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol, Metabolism 52 (2003), 1113-1116.
23. S. Yaturu, R.P. Daberry, J. Rains and S. Jain, Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes, Cytokine 34 (2006), 21-23.
24. W. Koeing, N. Khuseyinova, J. Baumert, C. Meisinger and H. L̈owel, Serum Concentrations of Adiponectin and Risk of Type 2 Diabetes Mellitus and Coronary Heart Disease in Apparently Healthy Middle-Aged Men: Results from the 18- years follow-up of a large cohort from southern Germany, JACC 48 (2006), 1369-1377.
25. A. Wiecek, M. Adamczak and J. Chudek, Adiponectin - an adipokine with unique metabolic properties, Nephrol Dial Transplant 22 (2007), 981-988.
26. M. von Eynatten, J.G. Schneider and P.M. Humpert, Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance, Diabetes Care 27 (2004), 2925-2929.
27. K. Sharma, S. RamachandraRao, G. Qiu, H.K. Usui, Y. Zhu, S.R. Dunn, R. Ouedraogo, K. Hough, P. McCue, L. Chan, B. Falkner and B.J. Goldstein, Adiponectin regulates albuminuria and podocyte function in mice, J Clin Invest 118 (2008), 1645-1656 .
28. M. Barton, Reversal of proteinuric renal disease and the emerging role of endothelin, Nature Clinical Practice Nephrology 4 (2008), 490-501.
29. C. Granier, K. Makni, L. Molina, B. Jardin-Watelet, H. Ayadi and F. Jarraya, Gene and protein markers of diabetic nephropathy, Nephrol Dial Transplant 23 (2008), 792-799.